Back to catalogue
№ 065 29 filings · 2022-01-11 → 2026-09-25

BANGO PLC

BGO
Technology Share price 71.70p Market cap £55m Overall fit 530 /1000

Strong operating leverage and fair valuation score well, but AI-receiver exposure is only indirect (platform that distributes AI subscriptions, not AI infrastructure), and quality is tempered by persistent GAAP losses and R&D capitalisation.

Fair value range 95p–140p Mid case · £91m
Absolute upside +65.4% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clear new segmental disclosure and consistent KPI reporting (ARR, NRR, Cash EBITDA)
  • Two consecutive years of broadly in-line delivery vs. guidance after FY23 miss
  • Cash EBITDA inflection visible and corroborated by 1H26 interim
Limits the call
  • Heavy capitalisation of R&D creates wedge between Adj. EBITDA and reported earnings
  • DVM scaling thesis still early — Subscriptions Cash EBITDA not yet positive (guided FY27)
Methodology

EV/Adj. EBITDA and EV/Cash EBITDA on FY26E consensus, ARR multiple cross-check

In one line · bull case

Platform-economics inflection: a 30%-growing subscription-bundling SaaS network (DVM) is finally translating into cash EBITDA, available at ~4x FY26E Adj. EBITDA while the market still prices the legacy DCB story.

In one line · biggest risk

DVM scaling thesis stalls (deal timing slippage, macro-driven sales-cycle elongation) while the DCB cash engine shrinks faster than expected, leaving Bango with insufficient operating leverage to close the GAAP-earnings gap.

Drivers
AI beneficiary 32 /100
DVM distributes AI subscriptions (Korea Telecom, RedSquid) but Bango itself is not a direct AI-infrastructure beneficiary; press-release AI language with limited captured value.
Operating leverage 80 /100
87% gross margin, 119% NRR, Subscriptions Adj. EBITDA tripled on 13% revenue growth — textbook platform leverage profile.
Earnings vs expectations 55 /100
One material miss (FY23), two subsequent years of broadly in-line delivery; recent trading updates reiterated consensus.
Growth momentum 70 /100
ARR +31% YoY to $20.4M, Subscriptions revenue +13%, Cash EBITDA accelerating — clear positive momentum.
Moat 55 /100
Growing two-sided network effect (7/8 top US telcos, 130+ content providers, zero live-customer churn) but platform still young vs. decade-plus structural moats.
Earnings quality 45 /100
Significant R&D capitalisation ($5.3M in 1H26); Cash EBITDA now a credible signal but reported earnings still obscured by heavy amortisation.
Management quality 55 /100
DOCOMO integration ran over but is now complete; CFO Wilson has delivered consistent disclosure and reiterated guidance since joining.
Cyclicality 30 /100
Subscription-economy platform with recurring revenue mix rising; low cyclicality beyond macro-driven sales-cycle elongation.
Leverage 30 /100
Net debt $8.7M on FY26E Adj. EBITDA $19.5M ≈ 0.4x; NatWest $15M RCF plus NHN term loan give flexibility.
Value-trap signals · 4
  • Payments segment revenue in managed decline (-15% FY25, -5% 1H26)
  • Persistent group-level net losses through FY25
  • Heavy R&D capitalisation inflates Adj. EBITDA vs. reported earnings
  • Historical customer concentration in Asian DCB partners

BANGO PLC (BGO) — Investment Research Note

Executive summary

Bango operates two complementary businesses: a cash-generative Direct Carrier Billing (DCB) payments segment (Google Play, Amazon Japan, NTT DOCOMO), and a rapidly scaling subscription-bundling platform — the Digital Vending Machine (DVM) — adopted by 7 of the top 8 US telcos. The three-year arc has been one of integration pain (DOCOMO Digital acquisition 2022), restructuring (2024-25), and finally a visible inflection in FY25/1H26: ARR +31% to $20.4M, group Adj. EBITDA margin stepping up from 17% (1H24) to 27% (1H25) to 35% (1H26), and Cash EBITDA turning materially positive. The single most important valuation point today is whether the DVM's platform economics (87% gross margin, 119% NRR, Subscriptions Adj. EBITDA tripling on 13% revenue growth) will deliver the operating leverage management is promising — because the current £57m market cap already discounts a lot of execution risk.

Fair value estimate

Range: 95p – 140p per share; implied market cap £73m – £108m

Methodology: blended EV/Adj. EBITDA and EV/Cash EBITDA on FY26E consensus, with sanity check vs. ARR multiple.

Assumptions:

  • FY26 consensus (per 1H26 trading update): revenue $53.8M, Adj. EBITDA $19.5M, Cash EBITDA $8.3M 2026-09 interim. Translated at ~1.33 USD/GBP: Adj. EBITDA ~£14.7m, Cash EBITDA ~£6.2m.
  • Net debt $8.7M (~£6.5m) at 30 June 2026 2026-09 interim.
  • Multiples: 7–10x FY26E Adj. EBITDA (small-cap UK SaaS/payments comp range), or 15–22x FY26E Cash EBITDA (reflecting continued deleveraging and FY27 inflection to Subscriptions Cash EBITDA positive, as guided 2026-04 FY25 results).
  • Low case 95p: ~7x EBITDA / 15x Cash EBITDA. High case 140p: ~10x EBITDA / 22x Cash EBITDA.
  • Mid ~117p vs current 74.5p = ~57% upside to the midpoint. Downside to the low end: +27%.

ARR cross-check: $20.4M ARR × 5x (reasonable for 30%+ growing SaaS with 119% NRR) = $102M = ~£77m — supports the lower half of the range.

Sector context

Technology / financial technology; payments & SaaS platforms. Bango sits in a hybrid niche: part DCB payments aggregator (comp: Boku Inc., Fonix Mobile, Digital Virgo), part B2B2C subscription-bundling SaaS (comp set less direct — perhaps Kaltura, Vonage historically, or private super-bundling plays). Quality profile is above typical AIM small-cap tech peers on gross margin (87%) and NRR (119%) but below on reported profitability (still group-level net loss) and scale (£57m cap). Growth profile is in line with mid-tier SaaS at ~30% ARR growth. Leverage is modest.

Investment thesis

  • Platform economics are starting to show. Subscriptions revenue +13% drove Subscriptions Adj. EBITDA from $1.0M to $3.2M (+224%), with group Adj. EBITDA margin stepping up 800bps YoY. NRR 119% means growth-from-base is largely incremental to profit 2026-09 interim. This is the exact "operating leverage to upside" profile the investor is targeting.
  • Entrenched network position. 7 of the top 8 US telcos, first wins in Japan (KDDI/povo), South Korea (Korea Telecom), MVNOs (Mobile Vikings), plus pan-European bank — the two-sided network effect is building, and churn of live DVM customers has been zero for multiple reporting periods 2026-04 FY25 results.
  • Valuation is undemanding on operational numbers. At ~4x FY26E Adj. EBITDA (EV basis) the market is still pricing Bango as a struggling DCB legacy, not as a platform compounding ARR at 30%+. Cash EBITDA inflected positive in FY25 and ran at $3.7M in 1H26 alone (vs. $2.3M for all of FY25), with FY27 guided to Subscriptions Cash EBITDA positive 2026-09 interim.

Key risks

  • Payments segment is in managed decline. DCB revenue fell 5% in 1H26 and management is actively restructuring low-margin routes; further "low-single-digit" revenue variance to consensus flagged for FY26 2026-09 interim. The cash engine funding DVM investment is shrinking.
  • Still loss-making at the bottom line; heavy R&D capitalisation. $5.3M of capitalised development in 1H26 vs. ~$0.3M operating profit. D&A ($8.0M in 1H26) exceeds Adj. EBITDA ex-capex of ~$3.7M. Earnings quality is clouded by the capitalise/amortise policy, and investors must trust Cash EBITDA as the real signal 2026-09 interim.
  • Thin AI alignment / macro cycle elongation. DVM customers now reference AI subscriptions (KT, RedSquid), but Bango is not a direct AI-infrastructure beneficiary; it is a distribution platform. Management also flags elongated sales cycles under macro uncertainty, and FY25 saw tier-1 DVM deals slip from Q4 to the following year — a repeat would hit ARR cadence 2026-01 trading update, 2026-04 FY25 results.

Operating leverage

Bango's cost base is predominantly fixed: 87% gross margin, core administrative expenses -15% YoY in 1H26 at $18.9M, headcount reduced from 219 (end-FY24) to 164 (end-FY25) with efficiency savings now fully in run-rate 2026-09 interim, 2026-04 FY25. The marginal gross margin on incremental DVM revenue is ~99% (management disclosure, FY25); incremental Payments revenue carries ~40%+ EBITDA margin. Illustrative sensitivity: FY26 consensus revenue $53.8M, Adj. EBITDA $19.5M. If Subscriptions revenue were 15% above plan (an extra ~$4M of Subscriptions, mostly high-margin NRR expansion), 70-80% drops to EBITDA = +$3M, lifting Adj. EBITDA to ~$22-23M (+15-20%). On a 20% revenue beat concentrated in the DVM, Adj. EBITDA could plausibly be 30-40% ahead. The inflection point to watch: Subscriptions Cash EBITDA, guided positive in FY27 — once reached, incremental DVM volume should flow very substantially to free cash flow.

Value-trap signals

  • Payments revenue in managed decline (−15% FY25, −5% 1H26).
  • Group-level loss persisting across multi-year window (FY25 loss $7.6M, 1H26 loss $0.7M); recurring exceptional items until FY25 ($6.4M).
  • Heavy capitalisation of R&D creates a wedge between Adj. EBITDA and GAAP earnings.
  • Customer concentration historically significant ($5.2M from one Asia partner in FY25).
  • DOCOMO Digital integration overran — 2+ year migration with multiple cost surprises uncovered post-deal. None of these are terminal, but together they explain the market's valuation discount.

Earnings vs. expectations

  • FY23 (reported Apr-24): Missed. Revenue beat but Adj. EBITDA ~$6.4M vs. market mid-high single-digits; late-cycle DOCOMO integration costs plus delayed DVM launches drove the miss 2024-04 FY23 results.
  • FY24 (reported Jun-25): Broadly in line on Adj. EBITDA ($15.3M) but with guidance for FY25 trimmed on timing and route restructuring 2025-06 FY24 results.
  • FY25 (reported Apr-26): In line on revenue, Adj. EBITDA, and Cash EBITDA; a positive Cash EBITDA inflection to $2.3M as flagged 2026-04 FY25 results.
  • 1H26 (reported Sep-26): In line; FY26 reiterated at consensus (revenue $53.8M, Adj. EBITDA $19.5M, Cash EBITDA $8.3M) with modest "low-single-digit" revenue variance flagged on route restructuring 2026-09 interim. Pattern: one meaningful miss (FY23), followed by two years of broadly in-line delivery and improving guidance discipline under the current CFO.

Conviction

3 — moderate. Anchors: clear segmental disclosure (Payments vs. Subscriptions) from FY26; multiple KPIs (ARR, NRR, Cash EBITDA) now consistently reported; consensus explicitly cited in filings; FY25 was audited unqualified. Limits: heavy R&D capitalisation makes operating profit hard to compare across years; valuation hinges on the DVM continuing to scale, which is still early (Subscriptions Cash EBITDA not yet positive); DCB cash engine in managed decline introduces timing uncertainty on the free-cash-flow bridge.

Filings consulted · 34

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-25Bango 1h26 Interim Results2026-09-25_9790237_bango-1h26-interim-results.md0.90
  2. 2026-09-03Notice OF Interim Results2026-09-03_9752894_notice-of-interim-results.md0.90
  3. 2026-07-091h26 Trading Statement2026-07-09_9659661_1h26-trading-statement.md0.85
  4. 2026-06-25Result OF Agm2026-06-25_9637648_result-of-agm.md0.30
  5. 2026-05-20Notice OF Agm2026-05-20_9576564_notice-of-agm.md0.30
  6. 2026-04-27Bango Fy25 Final Results2026-04-27_9538135_bango-fy25-final-results.md1.00
  7. 2026-01-20Trading Update2026-01-20_9367641_trading-update.md0.72
  8. 2025-09-15Half Year Report2025-09-15_9106885_half-year-report.md0.58
  9. 2025-08-28Notice OF Interim Results2025-08-28_9076565_notice-of-interim-results.md0.58
  10. 2025-07-24Trading Statement2025-07-24_8996329_trading-statement.md0.55
  11. 2025-06-30Result OF Agm2025-06-30_8955427_result-of-agm.md0.20
  12. 2025-06-06Notice OF Agm2025-06-06_8916030_notice-of-agm.md0.20
  13. 2025-06-06Bango Fy24 Final Results2025-06-06_8915988_bango-fy24-final-results.md0.65
  14. 2025-05-29Notice OF Results Amp Investor Presentation2025-05-29_8902694_notice-of-results-amp-investor-presentation.md0.46
  15. 2025-01-20Trading Statement2025-01-20_8695460_trading-statement.md0.55
  16. 2024-09-30Half Year Report2024-09-30_8448100_half-year-report.md0.41
  17. 2024-07-15Trading Statement2024-07-15_8310091_trading-statement.md0.38
  18. 2024-05-23Result OF Agm2024-05-23_8215876_result-of-agm.md0.14
  19. 2024-04-24Notice OF Agm2024-04-24_8153274_notice-of-agm.md0.14
  20. 2024-04-08Final Results2024-04-08_8124514_final-results.md0.45
  21. 2024-01-18Trading Statement2024-01-18_7994587_trading-statement.md0.38
  22. 2023-09-18Interim Results2023-09-18_7760499_interim-results.md0.23
  23. 2023-07-27Trading Update2023-07-27_7657725_trading-update.md0.21
  24. 2023-05-24Result OF Agm2023-05-24_7541763_result-of-agm.md0.07
  25. 2023-04-26Notice OF Agm2023-04-26_4454_notice-of-agm.md0.07
  26. 2023-03-31Availability OF Audited Annual Report2023-03-31_7380095_availability-of-audited-annual-report.md0.24
  27. 2023-01-24Trading Update2023-01-24_7499663_trading-update.md0.21
  28. 2022-09-29Interim Results2022-09-29_7168971_interim-results.md0.23
  29. 2022-08-02Trading Update2022-08-02_6956796_trading-update.md0.21
  30. 2022-05-25Result OF Agm2022-05-25_7026588_result-of-agm.md0.07
  31. 2022-04-27Annual Report And Notice OF Agm2022-04-27_7085539_annual-report-and-notice-of-agm.md0.24
  32. 2022-03-08Final Results2022-03-08_7062247_final-results.md0.25
  33. 2022-03-08Bango Annual Report Cover Released AS Nft2022-03-08_7063151_bango-annual-report-cover-released-as-nft.md0.24
  34. 2022-01-11FY 2021 Trading Update And Notice OF Results2022-01-11_6807720_fy-2021-trading-update-and-notice-of-results.md0.21

This research note was authored by a large language model after reading 29 regulatory filings published between 2022-01-11 and 2026-09-25. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.